| Position | Action |
|---|---|
| Core position | Maintain at ~5% cap weight |
| Price at $211.94 with $5 upside to $217 resistance | Do not add fresh capital |
| Confirmed retest of $203-205 zone (10 EMA/50 SMA) with constructive momentum | Allow tactical scaling |
| Closing price at or below $193.06 | Trigger hard stop - structural thesis break |
| Closing price below $205 | Trigger trailing stop - primary risk management line |
NVIDIA is compounding at a rate that makes 16x forward earnings with PEG of 0.55 an anomaly the market is in the process of resolving higher, backed by 85% YoY revenue growth, 74.9% gross margins, $96.7B FY26 FCF, and a fortress balance sheet with $68B net cash.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | 193.22 | bullish |
| 50 SMA | 205.65 | neutral |
| 10 EMA | 203.26 | bullish |
| RSI | 56.94 | bullish |
| MACD | -0.40 | neutral |
| MACD Signal | -0.92 | neutral |
| MACD Histogram | +0.52 | bullish |
| Bollinger Upper | 217.23 | neutral |
| Bollinger Middle | 204.60 | neutral |
| Bollinger Lower | 191.97 | neutral |
| ATR | 7.69 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Hold NVDA at ~5% cap weight; scale tactically on $203-205 retests with $205 trailing stop and $193.06 hard stop
Three-analyst consensus on Hold is confirmed for distinct reinforcing reasons: Aggressive analyst validates fundamentals (16.4x forward P/E ex-investment gains, 0.55 PEG, 114% ROE, $68B net cash, $96B trailing FCF, 85% YoY revenue growth) as structural anchor; Conservative analyst confirms tactical risk-reward unfavorable at $211.94 with only $5.29 upside against $18.72 downside to 200 SMA at $193.22; Neutral analyst reframes asymmetry favorably for existing holders with cost basis below $205. The $205 closing stop at 50 SMA serves as disciplined primary risk line; $193.06 closing basis remains structural thesis-break signal. The Aug 3 lesson informs loosened trim trigger (two-of-four vs four-of-four) to convert theoretical discipline into executed gains when momentum confirms.
When: Any 2 of 4: close >$212, volume >160M, MACD bullish cross, RSI >55
Then: Trim or take profits
Valuation at 16.4x forward P/E with PEG of 0.55 is anomalously cheap for this growth trajectory
↩ rebuts: “High P/E makes NVDA overvalued”
· concedes: Beta is 2.22 — volatility is real and is the price of admission; Retail positioning shows some crowding risk with chasing behavior visible on Reddit forums; ~$5 upside to resistance at $217.23 vs. support levels at $205.65 (50 SMA) and $193.22 (200 SMA)
NVDA at $211.94 is the wrong price for a stock whose bull case requires a perfect execution path that the data does not yet support — the risk/reward is unfavorably skewed for a fresh long.
· concedes: NVDA is a $5.1T franchise with a fortress balance sheet — the bear thesis is about timing and asymmetry, not the company being broken; The 200 SMA grinding higher ($190.73 → $193.22) is the only unambiguous bull signal in the chart — the long-term trend is intact; Fed pivoting dovish, a major hyperscaler announcing $100B+ multi-year AI capex expansion, or NVDA beating aggressive forward consensus by 20%+ would invalidate the bear case; The balance sheet lets the company buy back stock at lower prices when the cycle turns; Stocks can hold up better than the bear thesis implies in a soft-landing scenario
→ vs conservative: Anchoring on technical setup at $211 and framing $5 upside to $217 versus $18 downside to 200 SMA as unfavorable asymmetry is using the wrong reference frame; the 200 SMA is rising every day and will be at $195-$200 by the time anyone who sold waits for confirmation
→ vs conservative: Inventory and receivables are not smoking guns; the company has $68 billion net cash and a 3.44x current ratio, with receivables reflecting hyperscaler and sovereign contract structures, not collection risk; even if half receivables went bad, the company would remain net cash positive
→ vs conservative: Beta of 2.22 is not a risk with these fundamentals—it is an opportunity, as every flush is a gift
→ vs neutral: Waiting for 10 EMA to decisively cross 50 SMA is a lagging indicator giving signals after the move has already accelerated; the whole point of being long NVDA is to get paid before laggards confirm
→ vs neutral: Waiting for confirmation above $217 with 150 million volume means chasing the stock at $225-$230 instead of holding through consolidation, creating a guaranteed 5-8% performance drag
→ vs neutral: Treating this as a normal high-beta trade where mean reversion applies is incorrect; the fundamental picture is extraordinarily cheap on a forward basis (16.4x P/E, 0.55 PEG, 114% ROE)
→ vs neutral: Significantly underweighting the catalyst stack including SpaceX validating the platform in a new TAM vector that consensus models have basically zero priced in
| VWMA | 202.99 | bullish |
Support: 204.6 · 193.22 · 191.97 | Resistance: 217.23
Constructive HOLD with bullish bias. The long-term 200 SMA uptrend remains intact (193.22, rising from 190.73 on July 1), momentum has shifted positive with MACD histogram crossover and RSI recovery from oversold, and price reclaimed the 10 EMA and 50 SMA. However, no full buy trigger yet—the MACD line has not crossed zero, the 10 EMA has not decisively crossed above the 50 SMA (only $2.40 apart), and price is approaching the Upper Bollinger Band ($217.23) where supply historically reappears. Watch for either a pullback to the 50 SMA ($205.65) holding as support for a swing entry, or a confirmed break above $217.23 on rising volume for fresh longs. Traders already long should trail stops to the 10 EMA (~$203) or 50 SMA (~$205).
Market Cap
$5,133.4 B
Share Price
~$211.94
52-Week High
$236.54
52-Week Low
$164.07
TTM P/E
32.5x
Forward P/E
16.4x
PEG Ratio
0.55
P/B Ratio
26.26x
EPS (TTM)
$6.52
Forward EPS
$12.89
Dividend Yield
0.5%
Beta
2.215
Gross Margin (TTM)
74.1%
Operating Margin (TTM)
65.6%
Net Margin (TTM)
63.0%
ROE
114.3%
ROA
52.7%
Revenue Growth (FY26 YoY)
+65.5%
Net Income Growth (FY26 YoY)
+64.7%
EPS Growth (FY26 YoY)
+66.7%
FY26 Revenue
$215.9 B
FY26 Net Income
$120.1 B
FY26 Diluted EPS
$4.90
FY26 Operating Income
$130.4 B
FY26 Operating Cash Flow
$102.7 B
FY26 Free Cash Flow
$96.7 B
FY26 CapEx
$6.0 B
FY26 Buybacks
$40.1 B
FY26 Dividends
~$1.0 B
Cash + ST Investments (Q1 FY27)
$80.6 B
Total Debt
$12.3 B
Net Cash Position
~$68 B
Current Ratio
3.44x
Debt-to-Equity
6.6%
Q1 FY27 Revenue
$81.6 B
Q1 FY27 Revenue (QoQ)
+19.8%
Q1 FY27 Revenue (YoY)
+85.2%
Q1 FY27 Gross Margin
74.9%
Q1 FY27 Diluted EPS
$2.39
Q1 FY27 Net Income
$58.3 B
Q1 FY27 Operating Income
$53.5 B
Q1 FY27 Free Cash Flow
$48.6 B
Inventory (Q1 FY27)
$25.8 B
Receivables (Q1 FY27)
$40.7 B
Goodwill (Q1 FY27)
$20.9 B
EBITDA (TTM)
$165.5 B
FCF (TTM)
$46.3 B
Diluted Share Count (Q1 FY27)
24.39B
Tangible Book Value
$171.5 B
Working Capital (Q1 FY27)
$107 B
Strengths
Concerns
NVIDIA Corporation (NVDA) is a leading semiconductor company dominating AI training and inference silicon with exposure to hyperscalers and sovereign AI initiatives. The company delivered extraordinary FY26 results with $215.9B revenue (+65.5% YoY), $120.1B net income, and $96.7B FCF, while maintaining fortress-level balance sheet strength with $68B net cash. Q1 FY27 showed continued acceleration with $81.6B revenue (+85.2% YoY) and 74.9% gross margins, though TTM earnings include ~$25B in non-recurring investment gains that distort valuation metrics. With forward P/E of 16.4x and PEG of 0.55, the stock appears fundamentally undervalued relative to its growth trajectory, but elevated beta (2.22), customer concentration risk, AI capex cyclicality, and inventory buildup warrant careful position sizing. The FINAL TRANSACTION PROPOSAL is BUY, citing exceptional fundamentals, strong capital return program, and pullback entry opportunity ~10% below 52-week high.